MA33589B1 - Dérivé d'hétérocycle condensé et son utilisation - Google Patents
Dérivé d'hétérocycle condensé et son utilisationInfo
- Publication number
- MA33589B1 MA33589B1 MA34695A MA34695A MA33589B1 MA 33589 B1 MA33589 B1 MA 33589B1 MA 34695 A MA34695 A MA 34695A MA 34695 A MA34695 A MA 34695A MA 33589 B1 MA33589 B1 MA 33589B1
- Authority
- MA
- Morocco
- Prior art keywords
- condensed heterocycle
- heterocycle derivative
- smo
- derivative
- condensed
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009195770 | 2009-08-26 | ||
| JP2010015644 | 2010-01-27 | ||
| PCT/JP2010/064413 WO2011024872A1 (ja) | 2009-08-26 | 2010-08-25 | 縮合複素環誘導体およびその用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33589B1 true MA33589B1 (fr) | 2012-09-01 |
Family
ID=43627972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34695A MA33589B1 (fr) | 2009-08-26 | 2012-03-16 | Dérivé d'hétérocycle condensé et son utilisation |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8907089B2 (enExample) |
| EP (1) | EP2471790B1 (enExample) |
| JP (1) | JP5599802B2 (enExample) |
| KR (1) | KR20120078703A (enExample) |
| CN (1) | CN102574851A (enExample) |
| AU (1) | AU2010287492A1 (enExample) |
| BR (1) | BR112012004134A2 (enExample) |
| CA (1) | CA2771833A1 (enExample) |
| CL (1) | CL2012000461A1 (enExample) |
| CR (1) | CR20120095A (enExample) |
| DO (1) | DOP2012000048A (enExample) |
| EA (1) | EA201270311A1 (enExample) |
| EC (1) | ECSP12011747A (enExample) |
| GE (1) | GEP20146075B (enExample) |
| IL (1) | IL218323A0 (enExample) |
| IN (1) | IN2012DN02069A (enExample) |
| MA (1) | MA33589B1 (enExample) |
| MX (1) | MX2012002419A (enExample) |
| NZ (1) | NZ598749A (enExample) |
| PE (1) | PE20121326A1 (enExample) |
| SG (1) | SG178504A1 (enExample) |
| TN (1) | TN2012000084A1 (enExample) |
| WO (1) | WO2011024872A1 (enExample) |
| ZA (1) | ZA201201795B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2471793B1 (en) * | 2009-08-26 | 2016-10-05 | Takeda Pharmaceutical Company Limited | Fused heterocyclic ring derivative and use thereof |
| US9670221B2 (en) | 2013-03-14 | 2017-06-06 | Glaxosmithkline Intellectual Property (No. 2) Limited | Furopyridines as bromodomain inhibitors |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436965B1 (en) | 2000-03-02 | 2002-08-20 | Merck Frosst Canada & Co. | PDE IV inhibiting amides, compositions and methods of treatment |
| WO2002012189A1 (en) | 2000-08-09 | 2002-02-14 | Mitsubishi Pharma Corporation | Fused bicyclic amide compounds and medicinal use thereof |
| US7998986B2 (en) | 2001-12-21 | 2011-08-16 | Exelixis Patent Company Llc | Modulators of LXR |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| AU2003265853A1 (en) | 2002-08-29 | 2004-03-19 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
| WO2005033288A2 (en) * | 2003-09-29 | 2005-04-14 | The Johns Hopkins University | Hedgehog pathway antagonists |
| WO2005081960A2 (en) | 2004-02-25 | 2005-09-09 | Wyeth | Inhibitors of protein tyrosine phosphatase 1b |
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| US8273747B2 (en) | 2006-11-02 | 2012-09-25 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| WO2008057469A1 (en) * | 2006-11-02 | 2008-05-15 | Wyeth | Small organic molecule regulators of cell proliferation |
| CA2690953C (en) | 2007-06-29 | 2012-10-02 | Pfizer Inc. | Benzimidazole derivatives |
| RU2364597C1 (ru) * | 2007-12-14 | 2009-08-20 | Андрей Александрович Иващенко | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ |
| JP4685891B2 (ja) | 2008-02-19 | 2011-05-18 | 株式会社ハネックス | 分離装置 |
| CN102015705B (zh) * | 2008-02-26 | 2013-11-13 | 武田药品工业株式会社 | 稠合的杂环衍生物及其用途 |
| JP2010015644A (ja) | 2008-07-04 | 2010-01-21 | Fujitsu Ltd | スピンドル機構、電磁変換特性評価機、および情報記憶装置 |
| GB0900484D0 (en) | 2009-01-13 | 2009-02-11 | Angeletti P Ist Richerche Bio | Therapeutic agent |
-
2010
- 2010-08-25 EA EA201270311A patent/EA201270311A1/ru unknown
- 2010-08-25 PE PE2012000255A patent/PE20121326A1/es not_active Application Discontinuation
- 2010-08-25 CN CN2010800469387A patent/CN102574851A/zh active Pending
- 2010-08-25 WO PCT/JP2010/064413 patent/WO2011024872A1/ja not_active Ceased
- 2010-08-25 BR BR112012004134A patent/BR112012004134A2/pt not_active IP Right Cessation
- 2010-08-25 EP EP10811921.5A patent/EP2471790B1/en active Active
- 2010-08-25 JP JP2011528831A patent/JP5599802B2/ja active Active
- 2010-08-25 SG SG2012011599A patent/SG178504A1/en unknown
- 2010-08-25 IN IN2069DEN2012 patent/IN2012DN02069A/en unknown
- 2010-08-25 GE GEAP201012641A patent/GEP20146075B/en unknown
- 2010-08-25 NZ NZ598749A patent/NZ598749A/xx not_active IP Right Cessation
- 2010-08-25 KR KR1020127007793A patent/KR20120078703A/ko not_active Withdrawn
- 2010-08-25 AU AU2010287492A patent/AU2010287492A1/en not_active Abandoned
- 2010-08-25 US US13/391,791 patent/US8907089B2/en active Active
- 2010-08-25 MX MX2012002419A patent/MX2012002419A/es not_active Application Discontinuation
- 2010-08-25 CA CA2771833A patent/CA2771833A1/en not_active Abandoned
-
2012
- 2012-02-21 TN TNP2012000084A patent/TN2012000084A1/en unknown
- 2012-02-22 DO DO2012000048A patent/DOP2012000048A/es unknown
- 2012-02-23 CL CL2012000461A patent/CL2012000461A1/es unknown
- 2012-02-24 CR CR20120095A patent/CR20120095A/es not_active Application Discontinuation
- 2012-02-26 IL IL218323A patent/IL218323A0/en unknown
- 2012-03-12 ZA ZA2012/01795A patent/ZA201201795B/en unknown
- 2012-03-16 MA MA34695A patent/MA33589B1/fr unknown
- 2012-03-26 EC ECSP12011747 patent/ECSP12011747A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201270311A1 (ru) | 2012-09-28 |
| SG178504A1 (en) | 2012-04-27 |
| IL218323A0 (en) | 2012-04-30 |
| WO2011024872A1 (ja) | 2011-03-03 |
| CL2012000461A1 (es) | 2012-10-05 |
| TN2012000084A1 (en) | 2013-09-19 |
| US8907089B2 (en) | 2014-12-09 |
| ZA201201795B (en) | 2013-05-29 |
| BR112012004134A2 (pt) | 2017-06-20 |
| EP2471790A1 (en) | 2012-07-04 |
| PE20121326A1 (es) | 2012-10-11 |
| AU2010287492A1 (en) | 2012-03-29 |
| DOP2012000048A (es) | 2012-05-15 |
| MX2012002419A (es) | 2012-04-19 |
| US20120220570A1 (en) | 2012-08-30 |
| NZ598749A (en) | 2013-01-25 |
| JP5599802B2 (ja) | 2014-10-01 |
| JPWO2011024872A1 (ja) | 2013-01-31 |
| EP2471790B1 (en) | 2015-03-18 |
| ECSP12011747A (es) | 2012-05-30 |
| IN2012DN02069A (enExample) | 2015-08-21 |
| CR20120095A (es) | 2012-06-26 |
| CA2771833A1 (en) | 2011-03-03 |
| EP2471790A4 (en) | 2013-07-31 |
| CN102574851A (zh) | 2012-07-11 |
| GEP20146075B (en) | 2014-04-10 |
| KR20120078703A (ko) | 2012-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA32171B1 (fr) | Compose heterocyclique | |
| MA35085B1 (fr) | Procede de traitement d'une nephropathie induite par les produits de contraste | |
| MA33072B1 (fr) | Composes pyridazinone | |
| CR20200376A (es) | Inhibidores de cd73 | |
| MA37866B1 (fr) | Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur | |
| MA34713B1 (fr) | Compose bicyclique | |
| MA51431B1 (fr) | Dérivés d'oxy-fluoropipéridine utilisés en tant qu'inhibiteur de kinase | |
| MA51204B1 (fr) | Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique | |
| NO20080150L (no) | Inhibitorer av AKT-aktivitet | |
| JOP20220056A1 (ar) | مركبات rip1 تثبيطية وطرق عملها واستخدامها | |
| ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
| MA45940B1 (fr) | Composé hétérocyclique | |
| MA47217A (fr) | Composés de n-((hét)arylméthyl)hétéroaryle-carboxamides en tant qu'inhibiteurs de la kallicréine plasmatique | |
| MA29619B1 (fr) | Derive de 1,1 -dioxyde de 1,4-benzothiazepine, procede de preparation, medicaments comprenant ce compose, et utilisation de celui-ci comme hypolipidemiant | |
| EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
| MA31335B1 (fr) | Procédés de traitement impliquant l'inhibition de pi3k-alpha au moyen d'inhibiteurs de type quinaxoline | |
| MA30351B1 (fr) | Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation | |
| MA31873B1 (fr) | Inhibiteurs de la peptide déformylase | |
| WO2018182051A8 (en) | IP6K INHIBITORS | |
| MY139457A (en) | Liquid formulation | |
| MA38358A1 (fr) | Formulations de composés organiques | |
| MA29543B1 (fr) | Procedes pour traiter un cancer pharmacoresistant | |
| MA52297B1 (fr) | Composé hétérocyclique | |
| MA30523B1 (fr) | Compose tricylique et utilisation pharmaceutique de celui-ci | |
| MA46039B1 (fr) | Dérivé de triazolopyrazinone utile en tant qu'inhibiteur de pde1 humain |